# A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction

Study · id `cardio:ct-nct05126238` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05126238](<https://clinicaltrials.gov/study/NCT05126238>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05126238

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.

## Technical summary

Registry record NCT05126238. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-20 (actual); primary completion 2025-05-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT05126238, source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)
- Started: 2021-11-20 (actual) (ClinicalTrials.gov record NCT05126238, source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)
- Primary completion: 2025-05-19 (actual) (ClinicalTrials.gov record NCT05126238, source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)
- Completion: 2025-05-19 (actual) (ClinicalTrials.gov record NCT05126238, source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05126238, source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05126238-2025-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
- Condition: Carotid Artery Diseases
- Condition: Carotid Artery Stenosis
- Intervention (Drug): Lithium Carbonate
- Intervention (Drug): Placebo
- Lead sponsor: Negovsky Reanimatology Research Institute
- Lead sponsor class: OTHER\_GOV
- Collaborator: Demikhov Municipal Clinical Hospital 68
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: a01b83f7baccee515baaa85f614630282f5e59608509ea04ee3c6cf891a8ec1c
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
